Pricing

Regulations: Monitor, Understand and Foresee Evolution of Pricing and innovative contracting mechanisms, as well identify business related critical success factors, at International, National, and Regional level.
Stakeholders: Map important pricing stakeholders, understand and foresee their priorities, thinking, requirements and needs at national & subnational level.
Competitors : Monitor competitor prices, understand and foresee tactics; assess pricing competitive landscape; benchmark and assess strengths, weaknesses, opportunities and risks.
Policy: Monitor and Foresee Pricing Policy Evolution and Quantify Policy Regulatory business impact; Influence Pricing Policy Practices and Business Models, together with External Partners and Key Opinion Leaders in the specific business related field.
Disease: Comprehend and foresee therapy area and market dynamics, technology and epidemiology trends, therapeutic alternatives, management pathways, and unmet medical, humanistic, provider and payer needs.

Regulations: Pricing landscape assessment, Intelligence Collection, Trend Analysis and Insights, through desktop research, pricing stakeholder surveys, advisory boards, Delphi panels and Workshops business related.
Stakeholders: Stakeholder mapping studies, intelligence collection, insights, analysis of needs and wants, through desktop reviews, surveys, advisory boards, and workshops.
Competitors: Intelligence collection, benchmarking and risk mitigation analysis; Insights; Assessment of opportunities and risks through, Quantitative and Qualitative research.
Policy: Pricing policy monitoring, analysis and insights; policy impact evaluation; co-undertake thought leadership research and activities to influence and shape pricing policy practice in selected areas through publications and presentations.
Disease: Rapid, targeted or systematic reviews of disease, market, medical technology, guideline and patient management and assessments through desktop research, stakeholder surveys.

Alignment: Coordinate with other business functions; Review and provide input into the development of the target product profile and the Regulatory, Medical, Market Access, Evidence Generation and Brand Plans related to the business.
Capacities: Assess internal organisational capacities, experience, gaps, and priorities at global, regional and national level and plan to cover any weakness and gaps.
Engagement: Engage with relevant stakeholders in pricing, reimbursement, health technology assessment, payer, governmental agencies, academia, professional associations, committees, and patient advocacy groups.

Alignment: Provide cross functional alignment through workshops and facilitation; review and provide input into the development of the target product profile and the regulatory, medical, market access, evidence generation and brand plans.
Capacities: Review, undertake benchmarking and assess internal organisational capacities, to provide advice, training and support to cover gaps at different levels and functions.
Engagement: Identify and select stakeholders in relevant agencies and organisations, develop networks and engage effectively through scientific and advocacy events, research, and other relevant activities aiming to establish trusted relationships.

Strategy: Undertake research, to develop Life Cycle Pricing Strategic, Tactical and Risk Mitigation plans. General pricing guidance, sequencing and price floors; Develop and asses internal impact, and select financial and outcome-based pricing contracting options.
Τactics: Develop tactical plan for undertaking and implementing life cycle pricing negotiations and agreements at national and subnational (payer, provider, regional) level.

Strategy: Undertake qualitative and semi-quantitative pricing research, analytics, economic modelling and forecasting and prepare strategic, tactical and risk mitigation plans; Assess internal impact of alternative financial and outcome-based, pricing business scenarios.
Τactics: Key country and key account segmentation, monitor, implementation, engagement, risk mitigation, communication, financial and outcome-based contracting and management cross product life cycle plans.

Build Value Evidence: Build customisable economic models, dossiers, and communication tools to demonstrate value for money, estimate budget impact and effects of intelligent contracting agreements.

Build Value Evidence: Undertake evidence generation studies; build or customise health economic models and evidence dossiers to demonstrate and communicate value and to support optimum price attainment.

Infrastructure: Train, Guide and Support staff engaging in pricing negotiations with stakeholders; Develop corporate internal infrastructure and operation skills; Integrate pricing to functional domains and develop business alignment.
Negotiation: Manage engagement and negotiations with national or subnational authorities and key accounts to achieve best possible price and to negotiate and implement innovative contracting schemes throughout product lifecycle.

Infrastructure: Undertake bespoke training on soft and technical skills development; give advice on organisational issues and capacity development; organise internal brainstorming and alignment workshops; facilitate cross-functional collaboration.
Negotiation: Support client submissions and negotiations with stakeholders with tailor made analytics, scenario appraisal, value or formulary report and model customisations, advisory work, intelligence and insights, presentations, internal cross function workshops, monitoring and advisory boards.